Joanne M. Foody - 19 Jul 2022 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Chief Medical Officer
Signature
/s/ Sheldon L. Koenig
Issuer symbol
ESPR
Transactions as of
19 Jul 2022
Net transactions value
-$25,552
Form type
4
Filing time
20 Jul 2022, 16:27:46 UTC
Previous filing
09 Jun 2022
Next filing
19 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale $25,552 -3,901 -3.5% $6.55 109,077 19 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on quarterly vested shares of restricted stock units.